Search

everythinglearnresearchcommunity

for

Search:↓

Steroidogenic isoenzymes may help improve treatments for common hair loss.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Finasteride reduces testosterone conversion, progesterone lessens this, and levamisole enhances finasteride's effect.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

Plant-based compounds may offer safer prostate cancer treatment with fewer side effects.

Men on 5-alpha-reductase inhibitors might have worse COVID-19 outcomes.

Personalized treatment is crucial for effectively managing benign prostatic hyperplasia (BPH).

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Finasteride effectively reduces hair loss by decreasing androgen levels.

Male pattern baldness involves three mechanisms and finasteride can help reverse it.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Consider benefits and risks of new alopecia treatments for safety.

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

Cuscuta reflexa extracts and an isolate promoted hair growth and could be natural treatments for hair loss.

Finasteride use during early pregnancy may cause limb deformities in babies.

Policosanol helps treat hair loss by balancing hormones and supporting hair growth.

Eurycoma longifolia extract may help increase testosterone levels and reduce andropause symptoms.

The conclusion is that hair supplement ingredients may be unsafe and should be disclosed and proven safe before use.

Hair loss is linked to heart disease and metabolic syndrome, and while current treatments vary in effectiveness, more research is needed for better solutions.

5-alpha reductase inhibitors slightly increase depression risk, but the risk varies based on the control group used.

5-alpha reductase inhibitors may increase depression risk by 31%, but results vary based on comparison groups.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

No method fully prevents hair loss from chemotherapy, but some methods can reduce it and improve quality of life.

Men with male pattern baldness may not have different hormone levels, but their hair follicles are likely more sensitive to hormones.

Male pattern baldness involves genetics, hormones, and needs better treatments.